Atlas Trials

Epidermolysis Bullosa Dystrophica, Dominant

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Epidermolysis Bullosa Dystrophica, Dominant

RecordFirmDate
A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene (NCT03605069)Phoenicis Therapeutics2018-07-02

Track Epidermolysis Bullosa Dystrophica, Dominant automatically

Every clearance here is in the API, with alerts when new ones post.